AdvtJoin the community of 2M+ industry professionals. Subscribe to Newsletter to get latest insights & analysis in your inbox. Download the ETPharma App and get the Realtime updates and Save your favourite articles. It received accelerated approval for the indication in 2022.Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. (Reporting by Sriparna Roy in Bengaluru; Editing by Alan Barona and Sahal Muhammed)>

Source: Economic Times March 06, 2026 03:27 UTC